Matti A Rookus

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. ncbi Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
  2. ncbi Cancer risk in DES daughters
    Janneke Verloop
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cancer Causes Control 21:999-1007. 2010
  3. ncbi Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
  4. ncbi Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Breast Cancer Res Treat 120:235-44. 2010
  5. ncbi Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    J Clin Epidemiol 64:1434-43. 2011
  6. ncbi Body weight and risk of breast cancer in BRCA1/2 mutation carriers
    Peggy Manders
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 126:193-202. 2011
  7. ncbi Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands
    Eur J Epidemiol 25:103-13. 2010

Collaborators

  • Anouk Pijpe
  • Encarna B Gomez-Garcia
  • Christi J van Asperen
  • Ans van den Ouweland
  • RenĂ©e L Mulder
  • Cora M Aalfs
  • Laura J Van't Veer
  • Mieke Kriege
  • Marie Stenmark-Askmalm
  • Georgia Chenevix-Trench
  • Siranoush Manoukian
  • Barbara Pasini
  • Esther M John
  • Ute Hamann
  • Peggy Manders
  • Fergus J Couch
  • Anna Marie Mulligan
  • Isabelle Mortemousque
  • Sylvie Mazoyer
  • Debra Frost
  • Xianshu Wang
  • Theo A van Os
  • Paolo Radice
  • Hanne E J Meijers-Heijboer
  • Trinidad Caldes
  • Caroline Seynaeve
  • Daniela Zaffaroni
  • Senno Verhoef
  • Olga M Sinilnikova
  • Heli Nevanlinna
  • Alessandra Viel
  • Rosemarie Davidson
  • Javier Benitez
  • Jackie Cook
  • D Gareth Evans
  • Juul Wijnen
  • Louise Izatt
  • Margreet G E M Ausems
  • Laura Ottini
  • Katherine L Nathanson
  • Mary B Daly
  • Conxi Lazaro
  • Tuomas Heikkinen
  • Ramunas Janavicius
  • Lesley McGuffog
  • Fiona Lalloo
  • Susan M Domchek
  • Antonella Savarese
  • Andrew K Godwin
  • Susan Peock
  • Paolo Peterlongo
  • Antonis C Antoniou
  • Theo van Os
  • Ignacio Blanco
  • Loris Bernard
  • Zachary Fredericksen
  • Griselda Martrat
  • Bernard Peissel
  • Sue Healey
  • Ana Osorio
  • Dominique Stoppa-Lyonnet
  • Douglas F Easton
  • Flora E van Leeuwen
  • Janneke Verloop
  • Christian F Singer
  • Rosa B Barkardottir
  • Jenny Gross
  • Mark Robson
  • Mark Sherman
  • Maroulio Pertesi
  • Peter Devilee
  • Pascaline Berthet
  • Martine Dumont
  • Hans F A Vasen
  • Olufunmilayo Olopade
  • Yuan Chun Ding
  • von Anna Wachenfeldt
  • Wolfram Heinritz
  • Amanda Spurdle
  • Kenneth Offit
  • Juan Bueren
  • Torben A Kruse
  • Richard M Brohet
  • Susan J Ramus
  • Laura Papi
  • Thomas vO Hansen
  • Eitan Friedman
  • Mark H Greene
  • Jeffrey N Weitzel
  • Maartje Hooning

Detail Information

Publications7

  1. ncbi Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
    ..It is currently unknown how these alleles are associated with different breast cancer subtypes in BRCA1 and BRCA2 mutation carriers defined by estrogen (ER) or progesterone receptor (PR) status of the tumour...
  2. ncbi Cancer risk in DES daughters
    Janneke Verloop
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cancer Causes Control 21:999-1007. 2010
    ..We examined long-term risk of cancer in women exposed to diethylstilbestrol (DES) in utero...
  3. ncbi Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
    ..To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens...
  4. ncbi Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Breast Cancer Res Treat 120:235-44. 2010
    ..Engaging in sports activity after age 30 was also inversely associated with breast cancer risk (HR = 0.63, 95%CI = 0.44-0.91). Our results indicate that sports activity may reduce the risk of breast cancer in BRCA1/2 mutation carriers...
  5. ncbi Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    J Clin Epidemiol 64:1434-43. 2011
    ..We assessed accuracy of self-reported lifetime mammography history by BRCA1/2 mutation carriers with and without breast cancer...
  6. ncbi Body weight and risk of breast cancer in BRCA1/2 mutation carriers
    Peggy Manders
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 126:193-202. 2011
    ..Carriers may reduce their risk of postmenopausal breast cancer by maintaining a healthy body weight throughout life...
  7. ncbi Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands
    Eur J Epidemiol 25:103-13. 2010
    ..More consistent reporting was mainly determined by a younger age at questionnaire completion. In conclusion, inconsistent self-report of diagnostic radiation by BRCA1/2 mutation carriers was mainly non-differential by disease status...